EFFECTS OF VARIOUS NATURAL ANTIOXIDANTS ON THE CU2+-MEDIATED OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN

被引:0
|
作者
MIURA, S
WATANABE, J
SANO, M
TOMITA, T
OSAWA, T
HARA, Y
TOMITA, I
机构
[1] UNIV SHIZUOKA, SCH PHARMACEUT SCI, SHIZUOKA 422, JAPAN
[2] UNIV SHIZUOKA, GRAD SCH HLTH SCI, SHIZUOKA 422, JAPAN
[3] NAGOYA UNIV, DEPT APPL BIOL SCI, CHIKUSA KU, NAGOYA, AICHI 46401, JAPAN
[4] MITSUI NORIN CO LTD, FOOD RES LAB, SHIZUOKA 426, JAPAN
关键词
LOW DENSITY LIPOPROTEIN (LDL); LIPID PEROXIDATION; EPIGALLOCATECHIN GALLATE; NATURAL ANTIOXIDANT; ANTIOXIDATIVE ACTIVITY; ATHEROSCLEROSIS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have reported in our previous paper that several flavan-3-ol derivatives (tea polyphenols) inhibited the Cu2+-mediated low density lipoprotein (LDL) oxidation in vitro. (-)-Epigallocatechin gallate (EGCG), in particular, exhibited strong inhibition. In this study, we have compared the antioxidative effects of EGCG with those of other natural antioxidants, such as flavonols, sesaminol, curcuminoid derivatives, tocopherol analogues, and theaflavins. The antioxidative effects were monitored by conjugated diene formation in LDL which was carried out at 37 degrees C with 5 mu M CuSO4 with or without antioxidants. Dibutyl hydroxytoluene (BHT) was used as a reference compound. The lag-time before the onset of conjugated diene formation was more than 100 min in the presence of 0.5 mu M EGCG, theaflavin, myricetin, quercetin, and sesaminol. The ability to prolong the lag-time was in the order of sesaminol > quercetin > EGCG > theaflavin greater than or equal to myricetin > BHT > alpha-tocopherol. Among the 4 tocopherol analogues used, alpha-tocopherol showed the strongest antioxidative activity. We have also studied the effects of EGCG, BHT, and alpha-tocopherol on cholesteryl ester (CE) degradation and apolipoprotein B 100 (apo B 100) fragmentation in the Cu2+-mediated oxidative modification of LDL. EGCG was the most effective inhibitor of CE degradation and apo B 100 fragmentation.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 50 条
  • [1] INHIBITION OF OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN BY ANTIOXIDANTS
    NIKI, E
    NOGUCHI, N
    GOTOH, N
    [J]. JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 1993, 39 : S1 - S8
  • [2] THIOL-MEDIATED OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN
    PARTHASARATHY, S
    STEINBERG, D
    [J]. ARTERIOSCLEROSIS, 1986, 6 (05): : A542 - A542
  • [3] SUSCEPTIBILITY OF LOW-DENSITY-LIPOPROTEIN TO OXIDATIVE MODIFICATION
    WITZTUM, JL
    [J]. AMERICAN JOURNAL OF MEDICINE, 1993, 94 (04): : 347 - 349
  • [4] PRESERVATION OF THE ENDOGENOUS ANTIOXIDANTS IN LOW-DENSITY-LIPOPROTEIN BY ASCORBATE BUT NOT PROBUCOL DURING OXIDATIVE MODIFICATION
    JIALAL, I
    GRUNDY, SM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02): : 597 - 601
  • [5] EFFECTS OF SEX-HORMONES ON SUSCEPTIBILITY OF LOW-DENSITY-LIPOPROTEIN TO COPPER MEDIATED OXIDATIVE MODIFICATION
    ZHU, XD
    MEEKINS, D
    BONET, B
    KNOPP, RH
    [J]. CLINICAL RESEARCH, 1993, 41 (01): : A26 - A26
  • [6] Interactive effects of polyphenols, tocopherol and ascorbic acid on the Cu2+-mediated oxidative modification of human low density lipoproteins
    Yeomans, VC
    Linseisen, J
    Wolfram, G
    [J]. EUROPEAN JOURNAL OF NUTRITION, 2005, 44 (07) : 422 - 428
  • [7] KETOCONAZOLE INHIBITS OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN
    DUSHKIN, MI
    ZENKOV, NK
    MENSHIKOVA, EB
    PIVOVAROVA, EN
    LYUBIMOV, GY
    VOLSKY, NN
    [J]. ATHEROSCLEROSIS, 1995, 114 (01) : 9 - 18
  • [8] PROBUCOL INHIBITS OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN
    PARTHASARATHY, S
    YOUNG, SG
    WITZTUM, JL
    PITTMAN, RC
    STEINBERG, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (02): : 641 - 644
  • [9] NOVEL ATHEROGENIC, OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN
    PARTHASARATHY, S
    [J]. DIABETES-METABOLISM REVIEWS, 1991, 7 (03): : 163 - 171
  • [10] HIGH-DENSITY-LIPOPROTEIN INHIBITS THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN
    PARTHASARATHY, S
    BARNETT, J
    FONG, LG
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1044 (02) : 275 - 283